Bellevue Group Ag has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $4.67 Billion distributed in 186 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ionis Pharmaceuticals Inc with a value of $409M, Argenx Se with a value of $403M, Revolution Medicines, Inc. with a value of $260M, Neurocrine Biosciences Inc with a value of $248M, and Alnylam Pharmaceuticals, Inc. with a value of $204M.
Examining the 13F form we can see an increase of $280M in the current position value, from $4.39B to 4.67B.
Bellevue Group Ag is based out at Kuesnacht, V8
Below you can find more details about Bellevue Group Ag portfolio as well as his latest detailed transactions.
Portfolio value
$4.67 Billion
Healthcare: $4.67 Billion
ETFs: $4.03 Million
Technology: $1.34 Million
Basic Materials: $1.29 Million
Consumer Cyclical: $843,000
Communication Services: $819,000
Stock Holdings Table Market Cap. of $10 Billions to $200 Billions
